ArticleBMC plant biology2025
Species concept of golden flower camellias in China.
Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Organellar genome evolution in Camellia tianeensis (Theaceae): comparative insights into RNA editing, codon usage, and DNA transfer between chloroplast and mitochondrion.BMC genomics · 2026Article
- Article
- Comparative chloroplast genomics clarifies the taxonomic status and supports molecular identification ofFrontiers in plant science · 2026Article
- Comparative plastome analysis and phylogenetic relationships of ChineseFrontiers in plant science · 2026Article
- An integrative approach for rapid authentication of different parts ofFrontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundGolden flower camellias are valued in China as oil crops, medicinal plants and beautiful ornamental species. Due to overexploitation, all species of golden flower camellias are seriously endangered and have been regarded as the "giant panda of the plant kingdom". Unfortunately, the evolutionary relationships among golden flower camellia species are poorly understood, leading to frequent misidentifications.
resultsIn this paper, we report our understanding of golden flower camellia species according to the phylogenies based on sequences of the internal transcribed spacer (ITS) and the whole chloroplast genome (cpG). We sequenced 95 ITS fragments and determined 65 cpGs. Combined with cleaned sequences downloaded from GenBank, the ITS dataset comprised 931 sequences representing 160 camellia taxa, and the cpG dataset included 322 genomes from 140 camellia taxa. Phylogenies based on both datasets suggested extensive interspecific hybridization and chloroplast genome capture events. Genome duplication and incomplete concerted evolution did not significantly affect phylogenetic reconstruction used for species identification based on ITS sequences.
conclusionsA total of 23 golden flower camellia species are currently recognized as occurring in China. The ITS sequences are sensitive enough to discriminate all the re-circumscribed species and the cpG data are useful for tracing their geographical origins. Compared to non-golden flower camellias, the golden flower camellias have much lower genetic diversity. Considering that there are very few populations and even very few individuals, the golden flower camellias should be strictly protected in situ and conserved in nurseries ex situ. Future research efforts should be devoted to documenting the origins of hybrid species, and ex situ conservation efforts should be made toward evaluation and expansion of genetic diversity coverage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.